AI-generated summary
The authors evaluated a low-fluence 1064-nm Q-switched Nd:YAG laser for café-au-lait macules, first comparing it with a 532-nm laser in six patients and then in a prospective trial of 32 patients with 39 lesions. The authors report that 74.4% of lesions showed clearance of at least 50.0%, with adverse events in 15.4% of patients. The trial had no relevant treatment control group and followed patients for 6 months.
- Participants
- 32
- Who or what was studied
- Patients with café-au-lait macules: 6 in a preliminary split-lesion comparison and 32 patients with 39 lesions in a subsequent prospective trial
- Wavelengths
- 1064, 532 nm
- Limits stated in the abstract
- The prospective trial had no relevant treatment control group and followed participants for only 6 months.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.